Order results by:
| Issue | Title | |
| Vol 3, No 5 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
| "... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
| Vol 3, No 4 (2007) | GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir | ||
| "... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..." | ||
| Vol 3, No 5 (2007) | COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007 | Abstract similar documents |
| M. V. Shestakova | ||
| "... Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases ESC-EASD 2007. ..." | ||
| Vol 4, No 3 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE . | Abstract similar documents |
| I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... Society of Cardiology (ESC), в состав которого входят European Association for Cardiovascular Prevention ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... Diabetes mellitus (DM) is one of the health and social problems of modern health care. The main ..." | ||
| Vol 3, No 4 (2007) | COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| An. A. Alexandrov | ||
| "... Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. ..." | ||
| Vol 4, No 4 (2008) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| I. Graham, D. Ata, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backe, Sh. Ebrahim, B. Gjelsvik, Ch. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reime, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano | ||
| "... ; fax: +353 1 414 3052; e-mail: ian.graham@amnch.ie Оригинальный текст опубликован в European Heart ..." | ||
| Vol 1, No 3 (2005) | EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood | ||
| "... European guidelines on cardiovascular disease prevention in clinical practice. ..." | ||
| Vol 4, No 3 (2008) | COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE | Abstract similar documents |
| S. A. Shalnova | ||
| Vol 1, No 3 (2005) | EDITORIAL COMMENTS ON “EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE” | Abstract similar documents |
| "... Editorial comments on “european guidelines on cardiovascular disease prevention in clinical ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
| M. N. Kovrigina, M. N. Mamedov | ||
| "... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..." | ||
| Vol 8, No 1 (2012) | PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE | Abstract similar documents |
| M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova | ||
| "... are an independent risk factor for cardiovascular disease. The possibilities of GMD prevention and early treatment ..." | ||
| Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
| M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
| "... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..." | ||
| Vol 5, No 1 (2009) | CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC | Abstract similar documents |
| I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov | ||
| "... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..." | ||
| Vol 12, No 5 (2016) | News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko | ||
| "... News of the European Society of Cardiology Congress (Rome, 2016) is reviewed. The results ..." | ||
| Vol 11, No 5 (2015) | News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko | ||
| "... News of the European Society of Cardiology Congress (London, 2015) is presented. The results ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..." | ||
| Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
| "... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..." | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 2, No 1 (2006) | COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY | similar documents |
| R. I. Striyk | ||
| Vol 2, No 1 (2006) | COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY | similar documents |
| O. N. Tkacheva | ||
| Vol 4, No 2 (2008) | 2007 GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (ENDING) | Abstract similar documents |
| "... The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension ..." | ||
| Vol 4, No 1 (2008) | 2007 GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (BEGINNING) | Abstract similar documents |
| "... The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension ..." | ||
| Vol 16, No 4 (2020) | The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... levels risk of developing cardiovascular complications and chronic kidney disease. The combination ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... on the management of patients with hypercholesterolemia, which were presented by American and European experts ..." | ||
| Vol 9, No 6 (2013) | FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS | Abstract similar documents |
| S. A. Boytsov, M. M. Lukyanov, A. V. Kontsevaya, A. D. Deev, Yu. A. Balanova, A. V. Kapustina, V. G. Klyashtorny, M. B. Hudyakov | ||
| "... -November (p<0.0001) were found. Cardiovascular mortality decreased from 2007 to 2012 by 32.4% and by 32 ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..." | ||
| Vol 3, No 3 (2007) | COMMENTS TO THE LATEST EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (2007) | Abstract similar documents |
| V. M. Gorbunov | ||
| "... Comments to the latest European Guidelines for the Management of Arterial Hypertension (2007). ..." | ||
| Vol 3, No 4 (2007) | NEWS OF CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY, VIENNA, SEPTEMBER 1-5, 2007 | Abstract similar documents |
| S. Yu. Marcevich | ||
| "... News of Congress of European society of cardiology, Vienna, September 1-5, 2007. ..." | ||
| Vol 6, No 6 (2010) | REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" | Abstract similar documents |
| A. A. Aleksandrov | ||
| "... , the effect of combined hypoglycemic therapy on long-term cardiovascular prognosis in patients with type 2 ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..." | ||
| Vol 1, No 1 (2005) | EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE | Abstract similar documents |
| Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen | ||
| "... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..." | ||
| Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
| V. V. Fomin | ||
| "... Mechanisms of renal disorders in cardiovascular diseases are presented. The main ..." | ||
| Vol 11, No 3 (2015) | PREVALENCE OF TYPE D PERSONALITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS ACCORDING TO THE ESSE STUDY CONDUCTED IN KEMEROVO REGION | Abstract similar documents |
| A. N. Sumin, O. I. Raykh, E. V. Indukaeva, G. V. Artamonova | ||
| "... in the development and carrying out programs of primary and secondary prevention of cardiovascular diseases. ..." | ||
| Vol 4, No 1-2 (2008): приложение | РЕКОМЕНДАЦИИ 2007 ГОДА ПО ЛЕЧЕНИЮ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ | Abstract similar documents |
| "... Оригинальный текс опубликован в European Heart Journal (2007) 28, 1462-1536| © 2007 Европейское общество ..." | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... revised. As a result, the updating has been done in the Recommendations of European Society of Cardiology ..." | ||
| Vol 13, No 5 (2017) | NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE | Abstract similar documents |
| O. M. Drapkina, A. A. Yafarova | ||
| "... , NAFLD can be considered as an additional risk factor of cardiovascular diseases. In this article we ..." | ||
| Vol 14, No 5 (2018) | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria | Abstract similar documents |
| Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta | ||
| "... Obesity is one of the leading and the most serious risk factors of cardiovascular diseases ..." | ||
| Vol 10, No 4 (2014) | DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the "atrial fibrillation" diagnosis ..." | ||
| Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
| M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
| "... hypertension therapy according to the new European recommendations. Choice of antihypertensive therapy is based ..." | ||
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... Chronic kidney disease (CKD) is characterized by increasing prevalence, catalyzing properties ..." | ||
| Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..." | ||
| Vol 12, No 4 (2016) | Fighting with obesity: the "gold standard" and new horizons | Abstract similar documents |
| O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov | ||
| "... , such as cardiovascular disease and type 2 diabetes. Therapy aimed at addressing the risk factors of adverse outcomes ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..." | ||
| Vol 14, No 5 (2018) | Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting | Abstract similar documents |
| A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash | ||
| "... of major adverse cardiovascular events in the groups with CMD (the diabetes group – 14.2% vs the pre ..." | ||
| Vol 16, No 4 (2020) | Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease | Abstract similar documents |
| O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova | ||
| "... Cardiovascular diseases are the leading cause of death both in the world and in the Russian ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... into the outpatient REgistry of CardioVAScular diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..." | ||
| Vol 3, No 3 (2007) | RECENT EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION (2007): WHAT IS NEW IN APPROACH TO CHOICE OF DRUG? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... Recent European Guidelines for the Management of Arterial Hypertension (2007): what is new ..." | ||
| Vol 16, No 2 (2020) | Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study | Abstract similar documents |
| S. A. Shalnova, S. A. Maksimov, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, V. I. Tarasov, I. A. Viktorova, A. N. Redko, N. N. Prishchepa, S. S. Yakushin, O. M. Drapkina | ||
| "... (GFR) categories of various levels, as well as associations with a number of cardiovascular diseases ..." | ||
| Vol 3, No 4 (2007) | EDUCATIONAL MASTER-CLASS ON ARTERIAL HYPERTENSION AND CARDIOVASCULAR RISK. MOSCOW, SEPTEMBER 12-13, 2007 | Abstract similar documents |
| "... Educational master-class on arterial hypertension and cardiovascular risk. Moscow, September 12-13 ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... primary prevention of atherosclerosis-mediated cardiovascular diseases. Primary medical prevention has ..." | ||
| Vol 16, No 1 (2020) | Obesity and Mechanisms of its Negative Impact on the Cardiovascular System | Abstract similar documents |
| S. V. Miklishanskaya, L. V. Solomasova, M. A. Mazur | ||
| "... , which create prerequisites for the development of cardiovascular diseases, as well as the existing ..." | ||
| Vol 12, No 4 (2016) | Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk | Abstract PDF (Eng) similar documents |
| F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva | ||
| "... .00001) and in women (535.1 vs 822.7; p<0.00001), and also in all age subgroups above 25 years. Cardiovascular diseases ..." | ||
| Vol 3, No 2 (2007) | OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina | ||
| "... are rationales to use it in patients with ischemic heart disease and diabetes mellitus. ..." | ||
| Vol 11, No 4 (2015) | DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY | Abstract similar documents |
| E. B. Akhmedova, B. U. Mardanov, M. N. Mamedov | ||
| "... Heart rate variability (HRV) in patients with ischemic heart disease, a life-threatening heart ..." | ||
| Vol 10, No 4 (2014) | QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER | Abstract similar documents |
| A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov | ||
| "... clinical guidelines. Material and methods. Patients with HT without ischemic heart disease, chronic heart ..." | ||
| Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
| "... population studies carried out in 1975-1982, the multicenter epidemiological study of cardiovascular diseases ..." | ||
| Vol 14, No 3 (2018) | HEART RATE LEVELS IN THE POPULATIONS OF THE RUSSIAN FEDERATION AND THE UNITED STATES OF AMERICA DURING THE THIRTY-YEAR PERSPECTIVE | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, A. V. Kapustina, A. D. Deev | ||
| "... -communicable diseases. Aim. To evaluate changes in mean levels of HR in the Russian Federation (RF ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 11, No 6 (2015) | Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) | Abstract similar documents |
| O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko | ||
| "... in outpatients with cardiovascular diseases allows identifying a subgroup of patients (more in men) who have ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... to provide high level of compliance in patients with cardiovascular diseases. ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 11, No 2 (2015) | THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) | Abstract similar documents |
| G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun | ||
| "... of cardiovascular disease and type 2 diabetes. In the presence of insulin resistance the effects of risk factors ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 10, No 1 (2014) | ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES | Abstract similar documents |
| J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili | ||
| "... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..." | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..." | ||
| Vol 3, No 3 (2007) | STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? | Abstract similar documents |
| R. G. Oganov, G. V. Pogosova | ||
| "... as models of working stress. Pathophysiological modes of interactions of stress and cardiovascular diseases ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..." | ||
| Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
| "... Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes ..." | ||
| Vol 13, No 3 (2017) | ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, M. V. Pisarev | ||
| "... with pleiotropic effect in patients with arterial hypertension and associated diseases (diabetes mellitus, obesity ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... outcomes in patients with atherosclerosis and diabetes mellitus type 2 (DM2). Material and methods. 154 ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... to evaluate its effectiveness in various cardiovascular diseases. ..." | ||
| Vol 15, No 1 (2019) | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences | Abstract similar documents |
| Zh. D. Kobalava, E. A. Troitskaya, E. L. Kolesnik | ||
| "... Steady increase in worldwide prevalence of hypertension and hypertension-related cardiovascular ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... diseases. Usually internists consider that vitamin В12 deficiency is associated with disturbances ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... heart disease (IHD); cerebral circulation disorders; lower respiratory tract infection; chronic ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... who continue to smoke. Smoking cessation is the most cost-effective strategy of cardiovascular disease ..." | ||
| Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
| M. S. Berezhnova | ||
| "... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 10, No 4 (2014) | MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich | ||
| "... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..." | ||
| Vol 16, No 6 (2020) | Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences? | Abstract similar documents |
| A. I. Kochetkov | ||
| "... pharmacological classes used in the treatment of this disease. To date, much attention is paid to both ..." | ||
| Vol 4, No 5 (2008) | CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
| D. A. Poddubnyy, A. P. Rebrov | ||
| "... cardiovascular risk factors (smoking, hyper- and dislipoproteinemia, body overweight, heredity and diabetes ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| Vol 14, No 5 (2018) | Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya | Abstract similar documents |
| T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova | ||
| "... abdominal type (OR 1.53), the family anamnesis of early cardiovascular diseases (OR 1.88)] and rs4340 ..." | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| "... fats on the development of cardiovascular diseases and acute complications due to atherothrombosis ..." | ||
| Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..." | ||
| 1 - 100 of 940 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
